Efficacy of Gamification in Enhancing User Engagement

N/A

Waitlist Available

Led By Stuart Zola

Research Sponsored by MapHabit, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study).

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a special software called MapHabit that includes game-like features and virtual reality to help people with mild to moderate Alzheimer's or related dementias stay engaged and remember things better. It aims to improve their quality of life and reduce the burden on their caregivers.

Eligible Conditions

Dementia
Gamification
Alzheimer's Disease
Assistive Technology

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study).

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) from baseline at 6 months

Change in Margaret Blenkner Research Center (MBRC) Caregiver Strain instrument from baseline at 6 months

Change in User Interaction and Engagement from baseline at 6 months

+1 more

Secondary study objectives

2-item Satisfaction Scale (SS-2)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Gamified InterventionExperimental Treatment1 Intervention

This condition will involve the implementation of an assistive technology software (named the MapHabit system) with added gamification features into the daily care of individuals with mild to moderate stage of dementia. The MapHabit System (MHS) is a commercially available visual mapping software application that utilize visual, audio, and text media to create step-by-step visual guides to assist individuals and their caregivers in structuring and accomplishing activities of daily living (ADLs). The application will be made available to families through compatible tablets.

Group II: Exploratory InterventionExperimental Treatment1 Intervention

The exploratory condition will be given the same MHS version as the active comparator (control condition). However, for this group, participants will also engage in virtual reality games throughout the duration of the study. These virtual reality games are integrated with the MHS and includes cognitive games revolving around mental acuity, motor skills, etc.

Group III: Non-gamified InterventionActive Control1 Intervention

This control condition acted as the active comparator to the experimental condition. The same assistive technology, the MapHabit system, will be given to a separate group of participants. The difference here will be that the software will be a version that does not include gamification features.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

The MapHabit system

2022

N/A

~50

Do I qualify?Apply below to find out